FDA Inspection 1232941 — MedImmune U.K. Limited
The FDA completed an inspection of MedImmune U.K. Limited on Mar 15, 2024 in Liverpool. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Biologics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Mar 15, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Liverpool (United Kingdom)